Patient Adherence: The Transformation of Loyalty Strategies

The approaches that many pharmaceutical companies are using to advance patient loyalty and adherence provide opportunities for optimization. These strategies are typically short-term and fail to appreciate the complex and personal issues surrounding a patient's individual barriers to compliance and persistency. There is a significant growing need for companies to move beyond addressing just the well-defined financial barriers. It is therefore now vital to create a more customized, patient-centric relationship program that will provide them with targeted interventions to forge patient relationships that will lead to better, longer-term adherence and health outcomes.

Frost & Sullivan, along with their panel of distinguished industry experts, will take a look at the changing dynamics in today's U.S. pharmaceutical industry. The panel will review traditional adherence programs, examine what is and is not working, and what the next steps are toward addressing the multiple barriers contributing to non-adherence.

For additional information, please visit http://ebroadcast.frost.com/loyalty